Absci
2.85
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About Absci
Absci Corporation, una compañía de descubrimiento de fármacos y dianas, proporciona candidatos a fármacos biológicos y líneas de células de producción utilizando una plataforma integrada de creación de fármacos para socios en los Estados Unidos. Su plataforma integrada de creación de fármacos permite la creación de productos biológicos al unificar los procesos de descubrimiento de fármacos y desarrollo de líneas celulares en un solo proceso. Absci Corporation se fundó en 2011 y tiene su sede en Vancouver, Washington.
Trade GPT
Similar Stocks
© 2025 Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.
Rockalpha Limited, operates from its Singapore headquarters at CapitaSky 808, 79 Robinson Road, Singapore 068897, with a regional office at Level 6, Core C, Cyberport 3, 100 Cyberport Road, Hong Kong.